|
IT1199374B
(it)
*
|
1984-05-15 |
1988-12-30 |
Alfa Farmaceutici Spa |
Processo per la preparazione di pirido-imidazo-rifamicine
|
|
IT1264494B1
(it)
*
|
1993-03-23 |
1996-09-24 |
Alfa Wassermann Spa |
Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter
|
|
US6861053B1
(en)
*
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
|
US7048906B2
(en)
|
1995-05-17 |
2006-05-23 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
|
|
US5981522A
(en)
*
|
1995-09-01 |
1999-11-09 |
Kaneka Corporation |
Treatment of disease caused by infection of Helicobacter
|
|
TW534813B
(en)
*
|
1997-02-28 |
2003-06-01 |
Kaneka Corp |
Treating agent for diseases due to infection with helicobacter
|
|
WO2003045319A2
(en)
*
|
2001-11-21 |
2003-06-05 |
Activbiotics, Inc. |
Targeted therapeutics and uses thereof
|
|
AU2002364162A1
(en)
*
|
2001-12-13 |
2003-06-30 |
Activbiotics, Inc. |
Sulfhydryl rifamycins and uses thereof
|
|
WO2004041240A1
(en)
*
|
2002-11-05 |
2004-05-21 |
Piero Chiarelli |
Controlled and continued delivery of rifaximin and/or other substances
|
|
US7820652B2
(en)
*
|
2003-09-24 |
2010-10-26 |
Activbiotics Pharma, Llc |
Regimen for the administration of rifamycin-class antibiotics
|
|
US7923553B2
(en)
*
|
2003-11-07 |
2011-04-12 |
Alfa Wassermann, S.P.A. |
Processes for the production of polymorphic forms of rifaximin
|
|
ITMI20032144A1
(it)
*
|
2003-11-07 |
2005-05-08 |
Alfa Wassermann Spa |
Forme polimorfe di rifaximina, processi per ottenerle e
|
|
US7902206B2
(en)
*
|
2003-11-07 |
2011-03-08 |
Alfa Wassermann, S.P.A. |
Polymorphic forms α, β and γ of rifaximin
|
|
US7906542B2
(en)
*
|
2004-11-04 |
2011-03-15 |
Alfa Wassermann, S.P.A. |
Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
|
|
US20080262024A1
(en)
*
|
2003-11-07 |
2008-10-23 |
Giuseppe Claudio Viscomi |
Rifaximin compositions and method of use
|
|
US7265107B2
(en)
*
|
2004-03-10 |
2007-09-04 |
Cumbre Pharmaceuticals Inc. |
Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
|
|
US7256187B2
(en)
*
|
2004-03-10 |
2007-08-14 |
Cumbre Pharmaceuticals Inc. |
Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
|
|
US7202246B2
(en)
*
|
2004-06-09 |
2007-04-10 |
Cumbre Pharmaceuticals Inc. |
Spiro-rifamycin derivatives targeting RNA polymerase
|
|
US20060210492A1
(en)
*
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Use of rifaximin for treatment and prevention of periodontal conditions
|
|
US8003118B2
(en)
*
|
2005-03-02 |
2011-08-23 |
Kodsi Robert E |
Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
|
|
US20060210483A1
(en)
*
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
|
|
DK1698630T3
(da)
*
|
2005-03-03 |
2014-12-08 |
Alfa Wassermann Spa |
Nye polymorfe former af rifaximin, fremgangsmåde for deres fremstilling og anvendelse deraf i de medicinske præparater
|
|
ITBO20050123A1
(it)
*
|
2005-03-07 |
2005-06-06 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
|
|
BRPI0614758A2
(pt)
|
2005-08-11 |
2011-04-12 |
Targanta Therapeutics Inc |
rifamicinas fosfonadas e usos destas para a prevenção e tratamento de infecções na articulação e osso
|
|
BRPI0708561A2
(pt)
|
2006-03-09 |
2011-06-07 |
Salix Pharmaceuticals Inc |
preparação farmacêutica, e métodos de tratamento de um indivìduo que sofre de um distúrbio anal, e de avaliação da eficácia de um tratamento de distúrbio anal em um indivìduo, monitoramento do progresso de um indivìduo sendo tratado para um distúrbio anal, ou um método de seleção de um indivìduo para o tratamento de distúrbio anal
|
|
AU2007281413B2
(en)
|
2006-08-02 |
2013-10-31 |
Christopher Jahraus |
Compositions and methods for the treatment of radiation proctosigmoiditis
|
|
ITMI20061692A1
(it)
|
2006-09-05 |
2008-03-06 |
Alfa Wassermann Spa |
Uso di polioli per ottenere forme polimorfe stabili di rifaximina
|
|
US8633234B2
(en)
*
|
2006-09-22 |
2014-01-21 |
Cipla Limited |
Rifaximin
|
|
US20080161337A1
(en)
*
|
2007-01-03 |
2008-07-03 |
Leonard Weinstock |
Use of Rifaximin for the Treatment of Chronic Prostatitis
|
|
US20080159987A1
(en)
*
|
2007-01-03 |
2008-07-03 |
Leonard Weinstock |
Use of Rifaximin for the Treatment of Restless Legs Syndrome
|
|
ITMI20071241A1
(it)
*
|
2007-06-20 |
2008-12-21 |
Solmag S P A |
Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
|
|
PL2011486T5
(pl)
|
2007-07-06 |
2016-09-30 |
Lupin Ltd |
Farmaceutyczne kompozycje rifaksyminy
|
|
US8383151B2
(en)
|
2007-07-06 |
2013-02-26 |
Lupin Limited |
Pharmaceutical compositions of rifaximin
|
|
US7709634B2
(en)
*
|
2007-09-20 |
2010-05-04 |
Apotex Pharmachem Inc. |
Amorphous form of rifaximin and processes for its preparation
|
|
CN102015725B
(zh)
*
|
2008-02-25 |
2014-10-22 |
萨利克斯药品有限公司 |
利福昔明的多种形式及其用途
|
|
US8486956B2
(en)
|
2008-02-25 |
2013-07-16 |
Salix Pharmaceuticals, Ltd |
Forms of rifaximin and uses thereof
|
|
US11779571B2
(en)
|
2008-02-26 |
2023-10-10 |
Salix Pharmaceuticals, Inc. |
Methods for treating irritable bowel syndrome (IBS)
|
|
MX2010009197A
(es)
|
2008-02-26 |
2010-11-22 |
Salix Pharmaceuticals Ltd |
Metodos para tratar padecimientos del intestino.
|
|
EP2294012B1
(en)
|
2008-05-07 |
2014-07-09 |
Salix Pharmaceuticals, Ltd. |
Administration of a bowel cleanser and an antibiotic for the treatment of bowel disease
|
|
WO2010019511A2
(en)
|
2008-08-13 |
2010-02-18 |
Targanta Therapeutics Corp. |
Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
|
|
BRPI0918997A2
(pt)
|
2008-09-26 |
2015-12-01 |
Aska Pharm Co Ltd |
agente para evitar e/ou tratar um disturbio gastrointestinal funcional.
|
|
EP4591862A3
(en)
|
2008-10-02 |
2025-10-15 |
Salix Pharmaceuticals, Inc. |
Methods of treating hepatic encephalopathy
|
|
US12285414B2
(en)
|
2008-10-02 |
2025-04-29 |
Salix Pharmaceuticals, Inc. |
Methods of treating hepatic encephalopathy
|
|
US8916193B2
(en)
|
2008-12-10 |
2014-12-23 |
Cipla Limited |
Rifaximin complexes
|
|
IT1397617B1
(it)
*
|
2009-04-20 |
2013-01-18 |
Alfa Wassermann Spa |
Nuovi derivati della rifamicina
|
|
NZ596851A
(en)
|
2009-06-02 |
2013-10-25 |
Salix Pharmaceuticals Ltd |
Methods of treating hepatic encephalopathy
|
|
MX2012002895A
(es)
|
2009-09-13 |
2012-05-22 |
Salix Pharmaceuticals Ltd |
Metodos para tratar el sindrome de intestino irritado (ibs).
|
|
ES2712080T3
(es)
|
2009-10-27 |
2019-05-09 |
Lupin Ltd |
Dispersión sólida de rifaximina
|
|
EP2503989A2
(en)
|
2009-11-23 |
2012-10-03 |
Cipla Limited |
Topical foam composition
|
|
US8952159B2
(en)
|
2009-12-28 |
2015-02-10 |
Silvio Massimo Lavagna |
Method for the production of amorphous rifaximin
|
|
JP5896380B2
(ja)
|
2010-02-18 |
2016-03-30 |
サリックス ファーマスーティカルズ，リミテッド |
感染症を治療するための方法
|
|
IT1398550B1
(it)
|
2010-03-05 |
2013-03-01 |
Alfa Wassermann Spa |
Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
|
|
JP6092629B2
(ja)
|
2010-03-10 |
2017-03-08 |
ルピン・リミテッドＬｕｐｉｎ Ｌｉｍｉｔｅｄ |
リファキシミン使用準備済懸濁液
|
|
US20120077835A1
(en)
|
2010-07-12 |
2012-03-29 |
Salix Pharmaceuticals, Ltd. |
Formulations of rifaximin and uses thereof
|
|
US8759513B2
(en)
|
2010-09-13 |
2014-06-24 |
Sequent Scientific Limited |
Polymorphic form of rifaximin and process for its preparation
|
|
EP2672970B1
(en)
|
2011-02-11 |
2018-08-01 |
Salix Pharmaceuticals, Ltd. |
Forms of rifaximin and uses thereof
|
|
EP2705042A1
(en)
|
2011-05-02 |
2014-03-12 |
Ranbaxy Laboratories Limited |
Rifaximin dimethylformamide solvate
|
|
ITMI20110890A1
(it)
|
2011-05-19 |
2012-11-20 |
A M S A Anonima Materie Sint & Affini S P A |
Polimorfo di rifaximina e processo per la sua preparazione
|
|
ITBO20110461A1
(it)
|
2011-07-29 |
2013-01-30 |
Alfa Wassermann Spa |
Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
|
|
RU2496475C2
(ru)
|
2011-10-26 |
2013-10-27 |
Александр Васильевич Иващенко |
Фармацевтическая композиция и набор для лечения бактериальных инфекций
|
|
EP2773205B1
(en)
|
2011-11-02 |
2024-05-22 |
Salix Pharmaceuticals, Inc. |
Rifaximin for retreating diarrhea-predominant irritable bowel syndrome
|
|
JP2015509105A
(ja)
|
2012-01-25 |
2015-03-26 |
サリックス ファーマスーティカルズ，リミテッド |
リファキシミン誘導体及びその使用
|
|
ITBO20120368A1
(it)
|
2012-07-06 |
2014-01-07 |
Alfa Wassermann Spa |
Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
|
|
WO2014091432A1
(en)
|
2012-12-12 |
2014-06-19 |
Ranbaxy Laboratories Limited |
Pharmaceutical compositions of rifaximin
|
|
EP2971062A2
(en)
|
2013-03-15 |
2016-01-20 |
ALFA WASSERMANN S.p.A. |
Method for diagnosing vaginal infections
|
|
CA2897758A1
(en)
|
2013-03-15 |
2014-09-18 |
Alfa Wassermann S.P.A. |
Rifaximin for use in the treating of vaginal infections
|
|
US20140308350A1
(en)
|
2013-04-12 |
2014-10-16 |
Alfa Wassermann S.P.A. |
Nsaid administration and related compositions, methods and systems
|
|
US9018225B1
(en)
|
2013-07-26 |
2015-04-28 |
Novel Laboratories |
Rifaximin crystalline forms and methods of preparation thereof
|
|
EP2927235B1
(en)
|
2014-03-31 |
2017-02-08 |
Euticals S.P.A. |
Polymorphic mixture of rifaximin and its use for the preparation of solid formulations
|
|
WO2015159275A2
(en)
*
|
2014-04-19 |
2015-10-22 |
Granules India Limited |
An improved process for the preparation of rifamycin derivatives
|
|
MX375805B
(es)
|
2014-05-04 |
2025-03-07 |
Salix Pharmaceuticals Inc |
Microbiota ibs y sus usos.
|
|
DK3143027T3
(da)
*
|
2014-05-12 |
2019-08-12 |
Alfasigma Spa |
Ny solvatiseret krystalform af rifaximin, fremstilling, sammensætninger og anvendelser heraf
|
|
EP2982764A1
(en)
|
2014-08-05 |
2016-02-10 |
ALFA WASSERMANN S.p.A. |
Identification of vaginal bacteria
|
|
US9988398B2
(en)
|
2016-06-07 |
2018-06-05 |
Cadila Healthcare Limited |
Crystalline form of rifaximin and process for its preparation
|
|
EP4137132A1
(en)
|
2016-09-30 |
2023-02-22 |
Salix Pharmaceuticals, Inc. |
Solid dispersion forms of rifaximin
|
|
IT201700091912A1
(it)
*
|
2017-08-08 |
2019-02-08 |
Biofer Spa |
Nuove pirido-imidazo rifamicine
|
|
MX386622B
(es)
*
|
2017-06-26 |
2025-03-19 |
Biofer Spa |
Derivados de pirido-imidazo rifamicina como agente antibacteriano
|